Given that CD137+ Tregs are more immunosuppressive than CD137− Tregs in the non-tumor environment [67,68] comprehensive understanding of the role of CD137+ Treg in the tumor microenvironment is warranted. Here, TNFRSF9 is linked to neoplasm.